BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30481332)

  • 1. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
    Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
    Ebrahimi-Ghiri M; Khakpai F; Zarrindast MR
    J Psychopharmacol; 2021 Jul; 35(7):875-884. PubMed ID: 33155516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.
    Busquets-Garcia A; Puighermanal E; Pastor A; de la Torre R; Maldonado R; Ozaita A
    Biol Psychiatry; 2011 Sep; 70(5):479-86. PubMed ID: 21684528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
    Nawata Y; Kitaichi K; Yamamoto T
    Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.
    Trigo JM; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1815-22. PubMed ID: 26490035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
    Sciolino NR; Zhou W; Hohmann AG
    Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
    Seillier A; Giuffrida A
    Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A; Fassini A; Scopinho A; Correa FM; GuimarĂ£es FS; Lisboa SF; Resstel LB
    J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A; Giuffrida A
    Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
    Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
    Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
    Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature.
    Aliczki M; Balogh Z; Tulogdi A; Haller J
    Behav Pharmacol; 2012 Aug; 23(4):348-57. PubMed ID: 22750842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.
    Anggadiredja K; Nakamichi M; Hiranita T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
    Neuropsychopharmacology; 2004 Aug; 29(8):1470-8. PubMed ID: 15085091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
    Fucich EA; Stielper ZF; Cancienne HL; Edwards S; Gilpin NW; Molina PE; Middleton JW
    J Neurophysiol; 2020 Feb; 123(2):707-717. PubMed ID: 31913777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.
    Adamczyk P; McCreary AC; Przegalinski E; Mierzejewski P; Bienkowski P; Filip M
    J Physiol Pharmacol; 2009 Sep; 60(3):119-25. PubMed ID: 19826190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
    Lomazzo E; Bindila L; Remmers F; Lerner R; Schwitter C; Hoheisel U; Lutz B
    Neuropsychopharmacology; 2015 Jan; 40(2):488-501. PubMed ID: 25100669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.